Begin1 is creating a veterinary‑backed canine supplement that fills nutritional gaps in premium dog diets, targeting joint, immune, and skin health with high‑absorption, natural ingredients. The product will be offered as a single‑serve chewable tablet through a direct‑to‑consumer subscription model, providing owners with a convenient, science‑based way to ensure their dogs receive a complete nutritional profile.
Funding
Funding not disclosed
Founders
Product
Problem
Dog owners often feel that despite providing high-quality food and basic supplements, their pets may still be missing essential nutrients for optimal health, leading to uncertainty about whether they are doing enough.
Solution
Begin1 is developing a targeted canine supplement designed to complement premium dog diets and address common nutritional gaps. The product will be formulated based on veterinary research to deliver bioavailable nutrients that support joint health, immunity, and overall vitality. By offering a convenient, daily dose, Begin1 aims to give owners confidence that their dogs receive a complete nutritional profile. The supplement will be available through a direct‑to‑consumer model with subscription options to ensure consistent supply. Launch is planned for 2026, with early‑access notifications for interested customers.
Target Audience
Primary customers are dog owners who prioritize premium nutrition and seek a simple, science‑based supplement to enhance their pets' health.
Features
- Veterinary‑backed formulation focusing on joint, immune, and skin health
- High‑absorption, natural ingredients with no artificial fillers
- Single‑serve chewable tablet for easy daily administration
- Subscription service with auto‑refill and flexible delivery intervals
- Transparent labeling and third‑party testing for purity and potency